Key statistics
On Tuesday, GeneDx Holdings Corp (WGS:NSQ) closed at 94.78, 71.80% above the 52 week low of 55.17 set on May 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 91.24 |
|---|---|
| High | 95.22 |
| Low | 91.24 |
| Bid | 88.00 |
| Offer | 96.10 |
| Previous close | 91.24 |
| Average volume | 816.58k |
|---|---|
| Shares outstanding | 28.90m |
| Free float | 25.34m |
| P/E (TTM) | 1,530.44 |
| Market cap | 2.74bn USD |
| EPS (TTM) | 0.0619 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Press releases
- GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
- GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
- GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
- GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
- GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
- GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
- GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
- JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
More ▼
